Systemic lupus erythematosus and infections: a retrospective study in Saudis

被引:58
作者
Al-Rayes, H.
M-Swailem, R.
Arfin, M.
Sobkil, S.
Rizvil, S.
Tariq, M.
机构
[1] Armed Forces Hosp, Res Ctr, Dept Pathol, Riyadh 11159, Saudi Arabia
[2] Armed Forces Hosp, Dept Med, Riyadh 11159, Saudi Arabia
关键词
infection; Saudis; SLE; systemic lupus erythematosus;
D O I
10.1177/0961203307079943
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study demonstrates demographic, clinical and laboratory characteristics with special reference to infections in Saudi patients with SLE. One-hundred and ninety-nine patients with SLE treated at Riyadh Armed Forces Hospital, Saudi Arabia over a period of 15 years (1990-2005) were retrospectively reviewed. There were 162 females and 37 males (4.4 : 1) with an average age of 35 years at onset of disease. Duration of diseases ranged from one to 23 years with a mean of 7.23 years. Some of the clinical characteristics of SLE patients observed were nephritis (53.7%), fever (53.26%), neuropsychological disorder (36.18%), malar/butterfly rash (27.6%), pulmonary disorder (22.6%), photosensitivity (21.6%), cardiac involvement (21.1%) and oral ulcers (19.09%). Infection was the major complication with 58.79% of SLE patient having suffered from various infections. A total of 22 species of pathogens including gram positive and gram negative bacteria, viruses and fungi were isolated from 117 SLE patients. Single to multiple episode of infection with various pathogens were recorded however, majority of patients harboured one or two species of pathogens. Bacterial infection was predominant (78.6%) followed by viral (28.2%) and fungal (28.2%) infections. Forty-four percent of SLE patients were found to be infected with organisms classified as opportunistic. The high incidence of infections in SLE patients may be attributed to the multiple intrinsic and extrinsic risk factors including deficiency of complement (C3 and C4), disease activity, renal impairment, use of glucocorticoid and cytotoxic drugs. It is concluded that more judicious use of corticosteroids and other immunosuppressive agents will be critical to limit the infections in SLE and a high alert and close monitoring of patients will ensure optimal patient outcome, both in terms of morbidity and mortality.
引用
收藏
页码:755 / 763
页数:9
相关论文
共 50 条
  • [31] Update on infections and vaccinations in systemic lupus erythematosus and Sjogren's syndrome
    Pasoto, Sandra G.
    Ribeiro, Ana C. M.
    Bonfa, Eloisa
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (05) : 528 - 537
  • [32] Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus
    Hou, Chengcheng
    Jin, Ou
    Zhang, Xi
    CLINICAL RHEUMATOLOGY, 2018, 37 (10) : 2699 - 2705
  • [33] Systemic lupus erythematosus and infections: Clinical importance of conventional and upcoming biomarkers
    Sciascia, S.
    Ceberio, L.
    Garcia-Fernandez, C.
    Roccatello, D.
    Karim, Y.
    Cuadrado, M. J.
    AUTOIMMUNITY REVIEWS, 2012, 12 (02) : 157 - 163
  • [34] Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus
    Chengcheng Hou
    Ou Jin
    Xi Zhang
    Clinical Rheumatology, 2018, 37 : 2699 - 2705
  • [35] Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality
    Goldblatt, F.
    Chambers, S.
    Rahman, A.
    Isenberg, D. A.
    LUPUS, 2009, 18 (08) : 682 - 689
  • [36] CLINICAL PROFILE AND RISK FACTORS OF MAJOR INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Jayachandran, Nambiar Veettil
    Rajasekhar, Liza
    Narsimulu, Gumdal
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (35): : 3868 - 3872
  • [37] Risk factors associated with infections in pregnant women with systemic lupus erythematosus
    Valviesse, Daniele Maia de Jesus
    Monteiro, Denise Leite Maia
    de Jesus, Nilson Ramires
    de Jesus, Guilherme Ribeiro Ramires
    Santos, Flavia Cunha
    Lacerda, Marcela Ignacchiti
    Rodrigues, Nadia Cristina Pereira
    Klumb, Evandro Mendes
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (04): : 536 - 541
  • [38] The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients
    Zhou, W. J.
    Yang, C. D.
    LUPUS, 2009, 18 (09) : 807 - 812
  • [39] Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study
    Tanaka, Yoshiya
    Mizukami, Akiko
    Kobayashi, Akihiro
    Ito, Chie
    Matsuki, Taizo
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (08) : 1609 - 1618
  • [40] Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study
    Nannini, C.
    Crowson, C. S.
    Matteson, E. L.
    Moder, K. G.
    LUPUS, 2009, 18 (05) : 394 - 399